Suppr超能文献

内皮型一氧化氮合酶(eNOS)、神经元型一氧化氮合酶(nNOS)、环磷酸鸟苷(cGMP)和蛋白激酶G介导了胰抑制素(一种源自嗜铬粒蛋白A的肽)对肝癌细胞生长和增殖的抑制作用。

eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.

作者信息

Díaz-Troya Sandra, Najib Souad, Sánchez-Margalet Víctor

机构信息

Department of Medical Biochemistry and Molecular Biology, School of Medicine, Investigation Unit, University Hospital Virgen Macarena, Av. Sanchez Pizjuan 4, Seville 41009, Spain.

出版信息

Regul Pept. 2005 Feb 15;125(1-3):41-6. doi: 10.1016/j.regpep.2004.07.031.

Abstract

Pancreastatin (PST), a chromogranin A-derived peptide, has an anti-insulin metabolic effect and inhibits growth and proliferation by producing nitric oxide (NO) in HTC rat hepatoma cells. When NO production is blocked, a proliferative effect prevails due to the activation a Galphaq/11-phospholipase C-beta (PLC-beta) pathway, which leads to an increase in [Ca2+]i, protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) activation. The aim of the present study was to investigate the NO synthase (NOS) isoform that mediates these effects of PST on HTC hepatoma cells and the possible roles of cyclic GMP (cGMP) and cGMP-dependent protein kinase. DNA and protein synthesis in response to PST were measured as [3H]-thymidine and [3H]-leucine incorporation in the presence of various pharmacological inhibitors: N-monomethyl-L-arginine (NMLA, nonspecific NOS inhibitor), L-NIO (endothelial nitric oxide synthase (eNOS) inhibitor), espermidine (neuronal nitric oxide synthase (nNOS) inhibitor), LY83583 (guanylyl cyclase inhibitor), and KT5823 (protein kinase G inhibitor, (PKG)). L-NIO, similarly to NMLA, reverted the inhibitory effect of PST on hepatoma cell into a stimulatory effect on growth and proliferation. Nevertheless, espermidine also prevented the inhibitory effect of PST, but there was no stimulation of growth and proliferation. When guanylyl cyclase activity was blocked, there was again a reversion of the inhibitory effect into a stimulatory action, suggesting that the effect of NO was mediated by the production of cGMP. PKG inhibition prevented the inhibitory effect of PST, but there was no stimulatory effect. Therefore, the inhibitory effect of PST on growth and proliferation of hepatoma cells may be mainly mediated by eNOS activation. In turn, the effect of NO may be mediated by cGMP, whereas other pathways in addition to PKG activation seem to mediate the inhibition of DNA and protein synthesis by PST in HTC hepatoma cells.

摘要

胰淀素(PST)是一种源自嗜铬粒蛋白A的肽,具有抗胰岛素代谢作用,并通过在HTC大鼠肝癌细胞中产生一氧化氮(NO)来抑制生长和增殖。当NO生成受阻时,由于Gαq/11-磷脂酶C-β(PLC-β)途径的激活,增殖效应占主导,这会导致细胞内钙离子浓度([Ca2+]i)升高、蛋白激酶C(PKC)激活以及丝裂原活化蛋白激酶(MAPK)激活。本研究的目的是探究介导PST对HTC肝癌细胞这些作用的一氧化氮合酶(NOS)同工型,以及环磷酸鸟苷(cGMP)和cGMP依赖性蛋白激酶的可能作用。在存在各种药理抑制剂的情况下,通过测量[3H] - 胸腺嘧啶核苷和[3H] - 亮氨酸掺入来测定PST刺激下的DNA和蛋白质合成:N - 单甲基 - L - 精氨酸(NMLA,非特异性NOS抑制剂)、L - NIO(内皮型一氧化氮合酶(eNOS)抑制剂)、亚精胺(神经元型一氧化氮合酶(nNOS)抑制剂)、LY83583(鸟苷酸环化酶抑制剂)和KT5823(蛋白激酶G抑制剂,(PKG))。与NMLA类似,L - NIO将PST对肝癌细胞的抑制作用转变为对生长和增殖的刺激作用。然而,亚精胺也能阻止PST的抑制作用,但不会刺激生长和增殖。当鸟苷酸环化酶活性受阻时,抑制作用再次转变为刺激作用,这表明NO的作用是由cGMP的产生介导的。PKG抑制可阻止PST的抑制作用,但没有刺激作用。因此,PST对肝癌细胞生长和增殖的抑制作用可能主要由eNOS激活介导。反过来,NO的作用可能由cGMP介导,而除PKG激活外的其他途径似乎介导了PST对HTC肝癌细胞DNA和蛋白质合成的抑制作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验